KORLANZA Trademark

Trademark Overview

On Tuesday, December 9, 2014, a trademark application was filed for KORLANZA with the United States Patent and Trademark Office. The USPTO has given the KORLANZA trademark a serial number of 79160247. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, May 6, 2022. This trademark is owned by Cardiorentis AG. The KORLANZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cardiovascular, renal, pulmonary and neuronal syndromes; pharmaceutical products for the treatment of acute decompensated heart failure; pharmaceutical products for the treatment of cardiovascular diseases or disorders
korlanza

General Information

Serial Number79160247
Word MarkKORLANZA
Filing DateTuesday, December 9, 2014
Status709 - CANCELLED - SECTION 71
Status DateFriday, May 6, 2022
Registration Number4834176
Registration DateTuesday, October 20, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 4, 2015

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of cardiovascular, renal, pulmonary and neuronal syndromes; pharmaceutical products for the treatment of acute decompensated heart failure; pharmaceutical products for the treatment of cardiovascular diseases or disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCardiorentis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameCardiorentis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameCardiorentis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Monday, March 20, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, February 23, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, February 23, 2023INVALIDATION PROCESSED
Friday, January 6, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, May 6, 2022CANCELLED SECTION 71
Tuesday, October 20, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, August 11, 2016NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 25, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, March 8, 2016FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, March 8, 2016FINAL DISPOSITION PROCESSED
Wednesday, January 20, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 20, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, August 4, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 4, 2015PUBLISHED FOR OPPOSITION
Wednesday, July 15, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 2, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 1, 2015ASSIGNED TO LIE
Saturday, June 27, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 11, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 11, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 8, 2015ASSIGNED TO LIE
Tuesday, June 2, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 7, 2015NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 17, 2015REFUSAL PROCESSED BY IB
Monday, March 30, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, March 30, 2015REFUSAL PROCESSED BY MPU
Saturday, March 28, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 27, 2015NON-FINAL ACTION WRITTEN
Monday, March 23, 2015ASSIGNED TO EXAMINER
Tuesday, February 24, 2015APPLICATION FILING RECEIPT MAILED
Wednesday, February 18, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 12, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

korlanza pharmaceutical treatment products cardiovascular failure heart disorders decompensated diseases neuronal